Recombinant human prolactin (rhPRL) promotes human beta cell survival by inhibiting apoptosis (2008)
Fonte: Diabetologia. Nome do evento: Annual Meeting of the European Association for the Study of Diabetes (EASD). Unidades: EACH, IQ
Assuntos: PROLACTINA, TRANSPLANTE DE PÂNCREAS, APOPTOSE
ABNT
LABRIOLA, Leticia et al. Recombinant human prolactin (rhPRL) promotes human beta cell survival by inhibiting apoptosis. Diabetologia. Berlin: Escola de Artes, Ciências e Humanidades, Universidade de São Paulo. . Acesso em: 25 ago. 2024. , 2008APA
Labriola, L., Terra, L. F., Garay-Malpartida, H. M., Mares-Guia, T. R. dos, & Sogayar, M. C. (2008). Recombinant human prolactin (rhPRL) promotes human beta cell survival by inhibiting apoptosis. Diabetologia. Berlin: Escola de Artes, Ciências e Humanidades, Universidade de São Paulo.NLM
Labriola L, Terra LF, Garay-Malpartida HM, Mares-Guia TR dos, Sogayar MC. Recombinant human prolactin (rhPRL) promotes human beta cell survival by inhibiting apoptosis. Diabetologia. 2008 ; 51 S95-S96 res. 215.[citado 2024 ago. 25 ]Vancouver
Labriola L, Terra LF, Garay-Malpartida HM, Mares-Guia TR dos, Sogayar MC. Recombinant human prolactin (rhPRL) promotes human beta cell survival by inhibiting apoptosis. Diabetologia. 2008 ; 51 S95-S96 res. 215.[citado 2024 ago. 25 ]